{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T19:53:01Z","timestamp":1785527581429,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.psychres.2022.114590","type":"journal-article","created":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T17:19:04Z","timestamp":1651425544000},"page":"114590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Comparative risks of all-cause mortality for Veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications"],"prefix":"10.1016","volume":"313","author":[{"given":"Ira R.","family":"Katz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin R.","family":"Szymanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen R.","family":"Marder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail","family":"Shotwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler C.","family":"Hein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas W.","family":"Bowersox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2022.114590_bib0001","series-title":"Practice Guideline for the Treatment of Schizophrenia","year":"2020"},{"key":"10.1016\/j.psychres.2022.114590_bib0002","series-title":"Epidemiology in Public Health","first-page":"247","article-title":"Case-control studies","author":"Aschengrau","year":"2020"},{"key":"10.1016\/j.psychres.2022.114590_bib0003","article-title":"Associations between off-label low-dose olanzapine or quetiapine and cardiometabolic mortality","author":"Berge","year":"2021","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.psychres.2022.114590_bib0004","series-title":"Care for Veterans with Psychosis in the Veterans Health Administration: FY15","author":"Bowersox","year":"2017"},{"key":"10.1016\/j.psychres.2022.114590_bib0005","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291798008186","article-title":"The unhealthy lifestyle of people with schizophrenia","volume":"29","author":"Brown","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2022.114590_bib0006","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1177\/0091270010368678","article-title":"Effect of antipsychotic medications on glucose and lipid levels","volume":"51","author":"Chaggar","year":"2011","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2022.114590_bib0007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/acps.12989","article-title":"Clozapine and all-cause mortality in treatment-resistant schizophrenia: a historical cohort study","volume":"139","author":"Cho","year":"2019","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2022.114590_bib0008","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1345\/aph.1Q697","article-title":"Safety of low doses of quetiapine when used for insomnia","volume":"46","author":"Coe","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.psychres.2022.114590_bib0009","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med. Care"},{"key":"10.1016\/j.psychres.2022.114590_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.4088\/JCP.7075su1c.04","article-title":"The effects of undertreated chronic medical illnesses in patients with severe mental disorders","volume":"70","author":"Fagiolini","year":"2009","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114590_bib0011","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0165-1781(01)00234-7","article-title":"l Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate","volume":"101","author":"Fontaine","year":"2001","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.psychres.2022.114590_bib0012","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2011.08.010","article-title":"Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells","volume":"36","author":"Gasso","year":"2012","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114590_bib0014","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00228-010-0839-9","article-title":"Prescription persistence and safety of antipsychotic medication: a national registry-based 3-year follow-up","volume":"66","author":"Gjerden","year":"2010","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.psychres.2022.114590_bib0015","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1176\/appi.ps.201500507","article-title":"The business case for expanded clozapine utilization","volume":"67","author":"Goren","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2022.114590_bib0016","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1176\/appi.ps.201500506","article-title":"Organizational characteristics of Veterans affairs clinics with high and low utilization of clozapine","volume":"67","author":"Goren","year":"2016","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2022.114590_bib0017","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/schbul\/sbu120","article-title":"The effect of clozapine on premature mortality: an assessment of clinical monitoring and other potential confounders","volume":"41","author":"Hayes","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2022.114590_bib0019","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","volume":"150","author":"Hennekens","year":"2005","journal-title":"Am. Heart J."},{"key":"10.1016\/j.psychres.2022.114590_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.schres.2004.05.015","article-title":"Suicidal risk during treatment with clozapine: a meta-analysis","volume":"73","author":"Hennen","year":"2005","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2022.114590_bib0021","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2215-0366(17)30078-0","article-title":"Years of potential life lost and life expectancy in schizophrenia: a systematic review and meta-analysis","volume":"4","author":"Hjorth\u00f8j","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.psychres.2022.114590_bib0022","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2022.114590_bib0023","first-page":"363","article-title":"Tobacco smoking and schizophrenia: re-examining the evidence","volume":"25","author":"Isuru","year":"2019","journal-title":"BR J. Psych. Adv."},{"key":"10.1016\/j.psychres.2022.114590_bib0024","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/appi.ps.201700162","article-title":"Addressing barriers to clozapine underutilization: a national effort","volume":"69","author":"Kelly","year":"2018","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2022.114590_bib0025","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/j.1600-0447.2006.00850.x","article-title":"Health behavior in psychiatric in-patients compared with a German general population sample","volume":"114","author":"Kilian","year":"2006","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2022.114590_bib0026","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.schres.2006.02.023","article-title":"Long-term combination antipsychotic treatment in VA patients with schizophrenia","volume":"84","author":"Kreyenbuhl","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2022.114590_bib0027","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1176\/ps.2007.58.4.489","article-title":"Long-term antipsychotic polypharmacy in the VA health system: patient characteristics and treatment patterns","volume":"58","author":"Kreyenbuhl","year":"2007","journal-title":"Psychiatr. Serv."},{"key":"10.1016\/j.psychres.2022.114590_bib0028","doi-asserted-by":"crossref","unstructured":"Lieberman, J.A., Stroup, T.S., McEvoy, J.P., Swartz, M.S., Rosenheck, R.A., Perkins, D.O., Keefe, R.S.E., Davis, S.M., Davis, C.E., Lebowitz, B.D., Severe, M.S., Hsiao, J.K., for the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators, 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N. Engl. J. Med. 353, 1209\u20131223 10.1056\/NEJMoa051688.","DOI":"10.1056\/NEJMoa051688"},{"key":"10.1016\/j.psychres.2022.114590_bib0029","doi-asserted-by":"crossref","unstructured":"Meltzer, H.Y., Alphs, L., Green, A.I., Altamura, A.C., Anand, A., Bertoldi, A., Bourgeois, M., Chouinard, G., Islam, M.Z., Kane, J., Krishnan, R., Lindenmayer, J.P., Potkin, S., 2003. InterSePT study group clozapine treatment for suicidality in schizophrenia international suicide prevention trial (InterSePT) Arch. Gen. Psychiatry 60, 82\u201391. 10.1001\/archpsyc.60.1.82.","DOI":"10.1001\/archpsyc.60.1.82"},{"key":"10.1016\/j.psychres.2022.114590_bib0030","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/s41386-019-0577-3","article-title":"Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis","volume":"45","author":"Mizuno","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2022.114590_bib0031","first-page":"S22","article-title":"Perceived barriers and facilitators of clozapine use: a national survey of Veterans affairs prescribers","author":"Moody","year":"2019","journal-title":"Fed. Pract."},{"key":"10.1016\/j.psychres.2022.114590_bib0032","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00127-007-0247-3","article-title":"Physical activity, dietary habits and coronary heart disease risk factor knowledge amongst people with severe mental illness: a cross sectional comparative study in primary care","volume":"42","author":"Osborn","year":"2007","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.psychres.2022.114590_bib0033","article-title":"Use of haloperidol versus atypical antipsychotics and risk of in-hospital death in patients with acute myocardial infarction: cohort study","volume":"360","author":"Park","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2022.114590_bib0034","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/pds.3567","article-title":"Mortality, attempted suicide, re-hospitalisation and prescription refill for clozapine and other antipsychotics in Sweden-a register-based study","volume":"23","author":"Weitoft","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.psychres.2022.114590_bib0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.euroneuro.2020.05.011","article-title":"Causes of death in clozapine-treated patients in a catchment area: a 10-year retrospective case-control study","volume":"36","author":"Rose","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2022.114590_bib0036","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1001\/archpsyc.64.10.1123","article-title":"A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time?","volume":"64","author":"Saha","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114590_bib0037","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1186\/s12888-014-0357-x","article-title":"Suicide risk in Veterans health administration patients with mental health diagnoses initiating lithium or valproate: a historical prospective cohort study","volume":"14","author":"Smith","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.psychres.2022.114590_bib0038","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1002\/wps.20699","article-title":"20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20)","volume":"19","author":"Taipale","year":"2020","journal-title":"World Psychiatry"},{"key":"10.1016\/j.psychres.2022.114590_bib0039","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.schres.2017.12.010","article-title":"Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia","volume":"197","author":"Taipale","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.psychres.2022.114590_bib0040","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1017\/S0033291720004535","article-title":"Antipsychotics and mortality \u2013 more clarity needed","volume":"50","author":"Taylor","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2022.114590_bib9999","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2008.09.017","article-title":"Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?","volume":"59","author":"Trifir\u00f2","year":"2009","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.psychres.2022.114590_bib0043","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/schbul\/sby052","article-title":"Clozapine and long-term mortality risk in patients with schizophrenia: a systematic review and meta-analysis of studies lasting 1.1-12.5 years","volume":"45","author":"Vermeulen","year":"2019","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.psychres.2022.114590_bib0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1037\/tam0000096","article-title":"Balancing safety against obstruction to health care access: an examination of behavioral flags in the VA health care system","volume":"5","author":"Weinberger","year":"2018","journal-title":"J. Threat Assess. Manag."},{"key":"10.1016\/j.psychres.2022.114590_bib0046","first-page":"1","article-title":"Differences in antipsychotic treatment discontinuation among Veterans with schizophrenia in the U.S. department of Veterans affairs","volume":"00","author":"Weiser","year":"2021","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2022.114590_bib0047","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/acps.13280","article-title":"An evaluation of the variation and underuse of clozapine in the United Kingdom","volume":"143","author":"Whiskey","year":"2021","journal-title":"Acta Psychiatr. Scand."},{"key":"10.1016\/j.psychres.2022.114590_bib0048","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1017\/S003329172000358X","article-title":"Viewpoint: do antipsychotics protect against early death? A critical view","volume":"50","author":"Whitaker","year":"2020","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2022.114590_bib0049","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.2146\/ajhp070279","article-title":"Association of antipsychotic and antidepressant drugs with Q-T interval prolongation","volume":"65","author":"Zemrak","year":"2008","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.psychres.2022.114590_bib0050","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1097\/YIC.0000000000000330","article-title":"Clozapine utilization at the United States Veterans health administration: a descriptive report of prescribing patterns and patient characteristics among operation enduring freedom\/operation Iraqi freedom Veterans","volume":"35","author":"Zuschlag","year":"2020","journal-title":"Int. Clin. Psychopharmacol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178122002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:55:05Z","timestamp":1759038905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178122002001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":46,"alternative-id":["S0165178122002001"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114590","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative risks of all-cause mortality for Veterans with schizophrenia with ongoing receipt of clozapine and other antipsychotic medications","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2022.114590","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"114590"}}